Why Migraine Prevention Matters in Primary Care ft. Dr. Jaclyn Duvall and Dr. Stewart Tepper

In this episode of NHF InSights™: Primary Care/APP edition, host Jaclyn Duvall, MD, is joined by Stewart Tepper, MD, to discuss why primary care and advanced practice providers are essential to improving outcomes and quality of life for people living with migraine disease. Primary care offices see the majority of patients presenting with the symptoms of migraine disease and are uniquely positioned to initiate diagnosis, start acute treatment earlier, and help prevent disease progression. This conversation focuses on practical strategies providers can use in busy practices, including quick screening approaches, when to begin preventive therapy, and how newer migraine-specific treatments are changing care. The episode also explores evolving clinical guidance supporting FDA approved migraine-specific medications as first-line therapy, and key findings from the TEMPLE Phase 3 trial comparing atogepant with topiramate. You’ll learn: - How to quickly screen and identify likely migraine disease in a busy clinic setting - When to initiate preventive therapy based on patient disability, not just frequency of attacks - How CGRP-targeted therapies and gepants are shifting first-line treatment decisions and should be considered earlier - What the TEMPLE study means for tolerability, effectiveness, and patient quality of life - Practical steps primary care clinicians can take to bring care and hope to patients This episode highlights how newer migraine-specific treatments, and confident prescribing in primary care, have the potential to significantly improve patient outcomes and quality of life. This episode is supported by AbbVie.